General Information of Drug (ID: DMZ0TGY)

Drug Name
CGS 21680 Drug Info
Synonyms
2-(4-(2-Carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine; Cgs 21680; CGS-21680; 120225-54-9; UNII-T5HB1E831H; T5HB1E831H; CHEMBL331372; CGS21680; 4-(2-((6-Amino-9-(N-ethyl-beta-D-ribofuranuronamidosyl)-9H-purin-2-yl)amino)ethyl)benzenepropanoic acid; CHEBI:73283; CGS 21680 hydrochloride; Benzenepropanoic acid, 4-(2-((6-amino-9-(N-ethyl-beta-D-ribofuranuronamidosyl)-9H-purin-2-yl)amino)ethyl)-; 2-[p-(2-Carboxyethyl)phenylethyl-Amino]-5'-N-Ethylcarboxamido Adenosine; [3H]CGS 21680
Cross-matching ID
PubChem CID
3086599
ChEBI ID
CHEMBL331372
CAS Number
CAS 120225-54-9
TTD Drug ID
D0J2UW

Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)

Term Name NES FDR q-val Tag % Leading Edge Genes
DNA replication 2.10 0.00e+0 34/36 (94.44%) RFC3;MCM3;POLE3;...
Ribosome biogenesis in eukaryotes 1.98 3.76e-3 52/108 (48.15%) NVL;POP4;GTPBP4;...
Dilated cardiomyopathy 1.88 1.00e-2 86/96 (89.58%) TGFB3;DES;PLN;...
Base excision repair 1.82 9.39e-3 29/33 (87.88%) POLE3;POLE2;POLE;...
Cell cycle 1.80 9.02e-3 110/124 (88.71%) TGFB3;DBF4;CDC20;...
Fanconi anemia pathway 1.80 1.25e-2 36/54 (66.67%) FANCL;USP1;RPA1;...
RNA polymerase 1.75 2.68e-2 23/31 (74.19%) POLR2L;POLR2I;POLR3K;...
Hypertrophic cardiomyopathy 1.70 4.51e-2 81/90 (90%) TGFB3;DES;ACTC1;...
Systemic lupus erythematosus 1.70 4.09e-2 45/135 (33.33%) C7;HLA-DPB1;HLA-DPA1;...
Spliceosome 1.69 3.83e-2 101/150 (67.33%) SNRPB;DDX23;NCBP1;...
Non-homologous end-joining 1.64 4.85e-2 11/13 (84.62%) DNTT;FEN1;PRKDC;...
Coronavirus disease -1.62 4.52e-2 215/232 (92.67%) RPL11;C2;F13A1;...
Synthesis and degradation of ketone bodies -1.62 4.48e-2 9/10 (90%) HMGCS2;BDH2;HMGCL;...
Amino sugar and nucleotide sugar metabolism -1.63 4.47e-2 38/48 (79.17%) MPI;HK3;CYB5R1;...
Bladder cancer -1.64 4.00e-2 40/41 (97.56%) MAPK3;NRAS;DAPK2;...
Measles -1.66 3.31e-2 133/139 (95.68%) PIK3R3;CSNK2A2;IFNAR2;...
Lipid and atherosclerosis -1.67 3.15e-2 190/215 (88.37%) HSP90B1;HSPD1;RAP1B;...
Arginine biosynthesis -1.68 3.14e-2 17/22 (77.27%) GLUD2;CPS1;GLUD1;...
Histidine metabolism -1.68 3.01e-2 16/22 (72.73%) MAOA;CNDP2;ALDH3B1;...
Kaposi sarcoma-associated herpesvirus infection -1.71 2.08e-2 172/193 (89.12%) JUN;FOS;FAS;...
Salmonella infection -1.72 1.77e-2 198/249 (79.52%) CYFIP2;AHNAK2;RIPK1;...
Osteoclast differentiation -1.73 1.62e-2 117/127 (92.13%) CTSK;LILRA5;PIK3R3;...
Influenza A -1.75 1.51e-2 156/172 (90.7%) TRADD;MAVS;RNASEL;...
RIG-I-like receptor signaling pathway -1.75 1.60e-2 64/70 (91.43%) MAPK13;CYLD;TRADD;...
Glycolysis / Gluconeogenesis -1.76 1.70e-2 56/67 (83.58%) HK3;ADH5;HK1;...
Hepatitis C -1.77 1.58e-2 139/157 (88.54%) NRAS;TRADD;MAVS;...
Sulfur metabolism -1.81 1.01e-2 9/10 (90%) MPST;PAPSS1;ETHE1;...
Pathogenic Escherichia coli infection -1.82 1.09e-2 152/197 (77.16%) CLDN8;RIPK1;ARF6;...
Other glycan degradation -1.86 9.85e-3 13/18 (72.22%) AGA;HEXA;MANBA;...
Steroid biosynthesis -1.90 5.37e-3 19/20 (95%) DHCR7;FDFT1;HSD17B7;...
NOD-like receptor signaling pathway -1.91 5.91e-3 145/181 (80.11%) MAVS;PLCB2;RNASEL;...
Lysosome -1.93 6.57e-3 115/128 (89.84%) CLTB;CLTA;NAGLU;...
Pentose phosphate pathway -1.95 5.91e-3 25/30 (83.33%) PFKP;PFKL;GPI;...
Legionellosis -1.95 6.76e-3 51/57 (89.47%) NFKB2;NFKB1;RAB1A;...
IL-17 signaling pathway -1.95 7.88e-3 84/94 (89.36%) CCL11;HSP90B1;JUN;...
NF-kappa B signaling pathway -1.96 9.46e-3 90/104 (86.54%) EDAR;GADD45B;TRAF5;...
TNF signaling pathway -2.01 5.91e-3 103/112 (91.96%) JUN;FOS;FAS;...
Necroptosis -2.03 7.88e-3 113/159 (71.07%) CHMP1B;TRAF5;CYLD;...
Ferroptosis -2.09 0.00e+0 36/41 (87.8%) VDAC2;FTL;SLC39A14;...
Mineral absorption -2.22 0.00e+0 48/60 (80%) FTL;SLC5A1;SLC34A2;...
×

Pharmacogenomic Perturbation Across Diseases and Tissues

Bone
Ewing sarcoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
SK-ES-1 CVCL_0627 Homo sapiens 0.12uM - 10uM 24H
TC-32 CVCL_7141 Homo sapiens 0.12uM - 10uM 24H
Osteosarcoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
U-2 OS CVCL_0042 Homo sapiens 0.12uM - 10uM 6H, 24H, 48H
Brain
Glioblastoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
U-251 MG CVCL_0021 Homo sapiens 0.12uM - 10uM 24H
YH-13 CVCL_1800 Homo sapiens 0.12uM - 10uM 24H
Glioma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
GI-1 CVCL_1230 Homo sapiens 0.12uM - 10uM 24H
Breast
Breast adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MCF7 CVCL_0031 Homo sapiens 0.12uM - 10uM 6H, 24H, 48H
MDA-MB-468 CVCL_0419 Homo sapiens 0.12uM - 10uM 24H
Breast ductal carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
BT-474 CVCL_0179 Homo sapiens 0.12uM - 10uM 24H
T-47D CVCL_0553 Homo sapiens 0.12uM - 10uM 24H
ZR-75-1 CVCL_0588 Homo sapiens 0.12uM - 10uM 24H
Colon
Colorectal adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
GP2d CVCL_1234 Homo sapiens 0.12uM - 10uM 24H
HT-29 CVCL_0320 Homo sapiens 0.12uM - 10uM 6H, 24H
SNU-407 CVCL_5004 Homo sapiens 0.12uM - 10uM 24H
Embryonic stem cell
Normal
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
WA09 (H9) Derived CVCL_9773 (WA09) Homo sapiens 0.12uM - 10uM 24H
Endometrium
Endometrial adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HEC-108 CVCL_2926 Homo sapiens 0.12uM - 10uM 24H
HEC-151 CVCL_2927 Homo sapiens 0.12uM - 10uM 24H
HEC-1-A CVCL_0293 Homo sapiens 0.12uM - 10uM 24H
HEC-251 CVCL_2928 Homo sapiens 0.12uM - 10uM 24H
HEC-265 CVCL_2929 Homo sapiens 0.12uM - 1.11uM 24H
Fibroblast
Nasopharyngeal carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
FIBRNPC CVCL_UK07 Homo sapiens 10uM 6H, 24H
Hematopoietic system
Normal
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
ASC CVCL_U602 Homo sapiens 10uM 24H
CJM CVCL_U797 Homo sapiens 0.12uM - 10uM 24H
Kidney
Normal (Immortalized)
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HA1E CVCL_0284 Homo sapiens 10uM 6H, 24H
Renal cell carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
RCC10RGB CVCL_1656 Homo sapiens 0.12uM - 10uM 24H
Rhabdoid tumor
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
G-401 CVCL_0270 Homo sapiens 0.12uM - 10uM 24H
Liver
Hepatoblastoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
Hep G2 CVCL_0027 Homo sapiens 10uM 6H
Hepatocellular carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
JHH-5 CVCL_1320 Homo sapiens 0.12uM - 10uM 24H
JHH-7 CVCL_1322 Homo sapiens 0.12uM - 10uM 24H
Lung
Lung adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A549 CVCL_0023 Homo sapiens 0.12uM - 10uM 6H, 24H, 48H
NCI-H1437 CVCL_1472 Homo sapiens 0.12uM - 10uM 24H
NCI-H1573 CVCL_1483 Homo sapiens 0.12uM - 10uM 24H
NCI-H838 CVCL_1594 Homo sapiens 0.12uM - 10uM 24H
Lung squamous cell carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
BEN CVCL_1081 Homo sapiens 0.12uM - 10uM 24H
HCC1588 CVCL_1263 Homo sapiens 0.12uM - 10uM 24H
HCC95 CVCL_1276 Homo sapiens 0.12uM - 10uM 24H
Non-small cell lung carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HCC515 CVCL_5134 Homo sapiens 10uM 6H, 24H
NCI-H2110 CVCL_1529 Homo sapiens 0.12uM - 10uM 24H
NCI-H2172 CVCL_1534 Homo sapiens 0.12uM - 10uM 24H
Small cell lung carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
NCI-H841 CVCL_1595 Homo sapiens 0.12uM - 10uM 24H
Muscle
Rhabdomyosarcoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A-204 CVCL_0134 Homo sapiens 0.12uM - 10uM 24H
Oral cavity
Oral squamous cell carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
BICR 6 CVCL_1086 Homo sapiens 0.12uM - 10uM 24H
Ovary
Ovarian carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
OVK18 CVCL_1629 Homo sapiens 0.12uM - 10uM 24H
Ovarian clear cell carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
ES-2 CVCL_3509 Homo sapiens 0.12uM - 10uM 24H
OVTOKO CVCL_3114 Homo sapiens 0.12uM - 10uM 24H
Ovarian cystadenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
OAW 28 CVCL_1611 Homo sapiens 0.12uM - 10uM 24H
OC 316 CVCL_1615 Homo sapiens 0.12uM - 10uM 24H
Ovarian endometrioid carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
TOV-112D CVCL_3612 Homo sapiens 0.12uM - 10uM 24H
Ovarian granulosa cell tumor
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
COV434 CVCL_2010 Homo sapiens 0.12uM - 10uM 24H
Pancreas
Pancreatic carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
YAPC CVCL_1791 Homo sapiens 0.12uM - 10uM 24H
Prostate
Prostate carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
22Rv1 CVCL_1045 Homo sapiens 0.12uM - 10uM 24H
LNCaP clone FGC CVCL_1379 Homo sapiens 0.12uM - 10uM 24H
PC-3 CVCL_0035 Homo sapiens 0.12uM - 10uM 6H, 24H
VCaP CVCL_2235 Homo sapiens 10uM 6H, 24H
Skin
Melanoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A-375 CVCL_0132 Homo sapiens 0.12uM - 10uM 6H, 24H
IGR-37 CVCL_1303 Homo sapiens 0.12uM - 10uM 24H
Mel-HO CVCL_1402 Homo sapiens 0.12uM - 10uM 24H
SH-4 CVCL_1692 Homo sapiens 0.12uM - 10uM 24H
SK-MEL-3 CVCL_0525 Homo sapiens 0.12uM - 10uM 24H
Stomach
Gastric adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
AGS CVCL_0139 Homo sapiens 0.12uM - 10uM 24H
MKN45 CVCL_0434 Homo sapiens 0.12uM - 10uM 24H
Gastric carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
IM95 CVCL_1305 Homo sapiens 0.12uM - 10uM 24H
Urinary bladder
Bladder carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
BC-3C CVCL_1079 Homo sapiens 0.12uM - 10uM 24H
Bladder transitional cell carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
CAL-29 CVCL_1109 Homo sapiens 0.12uM - 10uM 24H